CA Stock MarketDetailed Quotes

FRX Fennec Pharmaceuticals Inc

Watchlist
  • 8.490
  • 0.0000.00%
15min DelayMarket Closed Nov 29 16:00 ET
232.90MMarket Cap-157222P/E (TTM)

About Fennec Pharmaceuticals Inc Company

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Company Profile

SymbolFRX
Company NameFennec Pharmaceuticals Inc
Founded1998
MarketTSE
Employees29
Fiscal Year Ends12-31
Address68 TW Alexander Drive PO Box 13628
CityResearch Triangle Park
CountryUnited States of America
Zip Code27709
Phone+1 919 636-4530
Websitehttps://www.fennecpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey S. Hackman
  • Chief Executive Officer and Director
  • --
  • Christiana Cioffi, M.B.A.
  • Chief Strategy Officer
  • --
  • Pierre S. Sayad, M.S.
  • Chief Medical Officer
  • --
  • Terry Evans
  • Chief Commercial Officer
  • --
  • Robert Andrade
  • Chief Financial Officer and Principal Accounting Officer
  • 1.31M
  • Dr. Khalid Islam, PhD
  • Chairman of the Board
  • 225.23K
  • Rostislav Raykov
  • Director
  • 2.54M
  • Dr. Marco M. Brughera
  • Independent Director
  • 166.31K
  • Dr. Jodi A. Cook, PhD
  • Independent Director
  • 153.81K
  • Chris A. Rallis
  • Independent Director
  • 173.18K
Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data